- Sections
- C - Chimie; métallurgie
- C07K - Peptides
- C07K 14/21 - Peptides ayant plus de 20 amino-acides; Gastrines; Somatostatines; Mélanotropines; Leurs dérivés provenant de bactéries provenant de Pseudomonadaceae (F)
Détention brevets de la classe C07K 14/21
Brevets de cette classe: 522
Historique des publications depuis 10 ans
|
38
|
53
|
43
|
61
|
52
|
51
|
53
|
33
|
31
|
5
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| Pioneer Hi-Bred International, Inc. | 6264 |
44 |
| Glaxosmithkline Biologicals S.A. | 1701 |
36 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2737 |
24 |
| Aridis Pharmaceuticals Inc. | 29 |
11 |
| University of Maryland, Baltimore | 999 |
8 |
| The Board of Trustees of the University of Illinois | 2623 |
7 |
| Viventia Bio Inc. | 24 |
7 |
| Wake Forest University Health Sciences | 707 |
7 |
| President and Fellows of Harvard College | 5792 |
6 |
| Arch Biophysics, Inc. | 5 |
5 |
| Arne Forsgren AB | 7 |
5 |
| Plant Health Care, Inc. | 56 |
5 |
| Spogen Biotech Inc. | 106 |
5 |
| Zymergen Inc. | 287 |
5 |
| Applied Molecular Transport Inc. | 20 |
5 |
| Evonik Operations GmbH | 3879 |
5 |
| Corteva Agriscience LLC | 2494 |
5 |
| E. I. du Pont de Nemours and Company | 4345 |
4 |
| Evonik Degussa GmbH | 1574 |
4 |
| Affinivax, Inc. | 29 |
4 |
| Autres propriétaires | 320 |